Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer mediates osteoclastogenesis through two different pathways.

Hitoshi Inoue1, Kazuo Nishimura, Daizo Oka

  • 1Department of Urology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.

Cancer Letters
|May 14, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinoma.

Cancer treatment and research communications·2026
Same author

[OSTEOMYELITIS PUBIS AFTER RETROPERITONEOSCOPIC RADICAL PROSTATECTOMY TRIGGERED BY EXERCISE: A CASE REPORT].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·2025
Same author

[A Case of Long-Term Complete Remission by Pembrolizumab＋Axitinib, Cabozantinib for Papillary Renal Cell Carcinoma with Metastasis].

Hinyokika kiyo. Acta urologica Japonica·2025
Same author

[A Case of Venous Leiomyosarcoma of the Inferior Vena Cava Diagnosed Preoperatively as an Adrenal Tumor].

Hinyokika kiyo. Acta urologica Japonica·2025
Same author

Treatment of a left inguinal hernia with incarceration of the scope during colonoscopy: a case report and literature review.

Surgical case reports·2024
Same author

Laparoscopic extraperitoneal approach for lateral lymph node dissection for patients with metachronous lateral pelvic lymph node metastases following surgery for rectal cancer: a case series and short-term outcomes.

Surgical endoscopy·2024

Prostate cancer cell lines stimulate bone-resorbing osteoclastogenesis by increasing receptor activator of NF-kappaB ligand (RANKL) in osteoblasts and directly impacting osteoclast precursors. This suggests dual mechanisms driving bone destruction in prostate cancer metastasis.

Area of Science:

  • Oncology
  • Cell Biology
  • Bone Biology

Background:

  • Prostate cancer commonly metastasizes to bone, leading to osteolytic lesions.
  • Osteoclastogenesis, the formation of bone-resorbing cells, plays a critical role in bone metastasis.
  • Understanding the interaction between prostate cancer cells and bone cells is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the effects of various prostate cancer cell lines on osteoclastogenesis.
  • To determine the role of receptor activator of NF-kappaB ligand (RANKL) and osteoprotegerin (OPG) in this process.
  • To identify direct effects of prostate cancer factors on osteoclast precursors.

Main Methods:

  • Conditioned medium (CM) from four prostate cancer cell lines (LNCaP, DU145, PC3, MDA PCa 2b) was used.

Related Experiment Videos

  • Effects on mRNA expression of RANKL and OPG in mouse osteoblast (MC3T3-E1) cells were analyzed.
  • Coculture experiments with prostate cancer cells and osteoblasts were performed.
  • Osteoclast precursor differentiation and maturation were assessed in the presence of CM and/or soluble RANKL.
  • Expression of matrix metalloproteinase-9 (MMP-9) mRNA in osteoclast precursors was measured.

    • Main Results:

    • CM from all tested prostate cancer cell lines upregulated RANKL mRNA in osteoblasts but not OPG mRNA.
    • Coculture experiments confirmed RANKL induction by prostate cancer cells.
    • CM from LNCaP and DU145 cells significantly enhanced osteoclast maturation, both in the presence and absence of soluble RANKL.
    • This RANKL-independent effect on osteoclast maturation was not inhibited by OPG.
    • CM from DU145 cells increased MMP-9 mRNA expression in osteoclast precursors.

    Conclusions:

    • Prostate cancer cells promote osteoclastogenesis through osteoblast RANKL induction.
    • Prostate cancer cells also exert direct, RANKL-independent effects on osteoclast precursors.
    • These direct effects may involve factors that induce osteoclast maturation and MMP-9 expression.
    • These findings highlight a dual mechanism by which prostate cancer mediates bone destruction.